Boomerang Medical Raises $15M in Series A Financing
Heather Simonsen, President and Chief Executive Officer of Boomerang Medical. “We are especially proud to announce this financing as a woman-led company, after watching the proportion of venture funding dollars drop from 2.8 percent in 2019 to 1.9 percent thus far in 2022 for companies with a female at the helm, a decline we are helping to reverse."
Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation
Eagle Genomics advises the round is being led by abrdn plc, with continued participation from existing investors Environmental Technologies Fund, and a consortium of investors headed by Granpool Innovative Investments.
AgroSpheres Raises $22 million Series B
AgroSpheres notes the round was led by Lewis & Clark AgriFood and Ospraie Ag Science.
Day Zero Diagnostics Awarded $8.2 Million in Additional CARB-X Funding To Support Ongoing Development of its Infectious Disease Rapid Diagnostic
Day Zero Diagnostics received an initial $6.2 million CARB-X award in May of 2020. This latest award brings the total to over $16 million.
RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications
RenBio notes the goal of the $40.0 million New York State Biodefense Commercialization Fund is to accelerate the development and commercialization of innovations targeting infectious disease threats while fostering new life science businesses and industry growth within the State.
Nested Therapeutics Launches With $125 Million Financing
Financing will enable Nested Therapeutics to advance its pipeline programs, attract additional top-tier talent, and further develop its platform that reveals cryptic, or newly uncovered, driver mutations and pockets in high-conviction cancer targets to dramatically expand the reach of precision medicine.